Melanoma research gets a funding boost from NHMRC
A landmark study led by MIA's Dr Willmott is making a difference to melanoma treatment around the globe.
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.
The uniquely Aussie awareness campaign ‘Game On Mole’ is back for its second year – with a new look but same important message.
Professor Richard Scolyer receives The Royal College of Pathologists of Australasia Distinguished Fellow Award.
Professor Long cites as a highlight of her 2-year Presidency, the phenomenal research output by SMR members who have continued to lead the cancer field despite the impact of COVID-19.
Join in the fun of the virtual event, and together we can run over melanoma!
Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.
Participate in our online survey and help us understand the support needs of melanoma patients and carers.
Clinicians and their patients now have access to three online risk calculators developed by researchers at Melanoma Institute Australia.
MIA's Co-Medical Director Professor Richard Scolyer has received The University of Sydney Alumni Award for International Achievement.
More than 120 MIA clinicians, researchers and staff came together online to share research highlights.
For the 2nd consecutive year, MIA's Co-Medical Director Professor Richard Scolyer has been selected in the top 100 best, brightest, and most powerful advocates of pathology by The Pathologist.
As of Monday 27th July all patients and carers/family members coming into The Poche Centre will be required to bring their own mask.
In a recent issue of Cancer Cell journal, Prof Georgina Long AO and Prof Richard Scolyer discuss the challenge of bringing together clinical work and scientific research to underpin successful cancer research.
Clinicians around the world now have access to a new online calculator that predicts the risk that a patient’s primary melanoma has spread to nearby lymph nodes.
Professor Long has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine, particularly, to melanoma clinical and translational research, and to professional medical societies.
“I had a complete response within about six months. All of my tumours disappeared."
‘We are extremely proud of our ongoing contribution to the global effort to save lives from melanoma, with Dr Silva’s prestigious award proof that we continue to lead the way,'
'Being able to tell my children that I now have no evidence of disease was the best day ever!' Jen Benfield, Stage IV melanoma survivor
Thanks to the generosity of our MIA community, funds raised from the Christmas Appeal are supporting ongoing research to give other grandfathers like Paul a better chance of survival.
“I’m one of the lucky ones,” said Barbara. Barbara Holland was diagnosed with mucosal melanoma in 2015.
After 17 years being melanoma free, Jenny found out her melanoma had spread to her brain and to her lungs. She is now on the Anti-PD-1 trial.
Rick decided to sign up to a ground-breaking trial at Melanoma Institute Australia – a decision that has saved his life. He moved from Byron Bay to Bondi just to be closer to the Institute.
Nick's 16-year battle with melanoma has been made possible thanks to his family being by his side.
Family support and exceptional care at MIA has made the world of difference to Grant through his stage IV melanoma diagnosis.
Adam's shares his patient story about his experience with melanoma.
Ruth celebrates a very special Mother's Day with her gorgeous daughters.
Diagnosed with melanoma 37 years ago, Mike shares his story about treatment back then.
Life is there to be experienced.
Translational research creates results for inspiring patients like Trish.